Ovation Science Inc.
OVAT
CNSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -65.70% | 3.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -65.70% | 3.00% | |||
| Cost of Revenue | 150.00% | -94.70% | |||
| Gross Profit | -71.43% | 102.01% | |||
| SG&A Expenses | -26.81% | 1.90% | |||
| Depreciation & Amortization | -33.33% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.35% | -11.95% | |||
| Operating Income | 13.66% | 15.83% | |||
| Income Before Tax | -135.74% | 57.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -135.74% | 57.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -135.74% | 57.58% | |||
| EBIT | 13.66% | 15.83% | |||
| EBITDA | 13.53% | 15.91% | |||
| EPS Basic | -94.74% | 50.00% | |||
| Normalized Basic EPS | -91.67% | 50.00% | |||
| EPS Diluted | -94.74% | 50.00% | |||
| Normalized Diluted EPS | -91.67% | 50.00% | |||
| Average Basic Shares Outstanding | 19.98% | -14.09% | |||
| Average Diluted Shares Outstanding | 19.98% | -14.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||